These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 16162025

  • 1. Caspofungin: a review of its use in the treatment of fungal infections.
    McCormack PL, Perry CM.
    Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
    Maschmeyer G, Glasmacher A.
    Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
    [Abstract] [Full Text] [Related]

  • 5. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD, Lyseng-Williamson KA, Scott LJ.
    Drugs; 2009 Jul; 69(3):361-92. PubMed ID: 19275278
    [Abstract] [Full Text] [Related]

  • 6. Caspofungin.
    Keating GM, Jarvis B.
    Drugs; 2001 Jul; 61(8):1121-9; discussion 1130-1. PubMed ID: 11465873
    [Abstract] [Full Text] [Related]

  • 7. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD, Perfect JR.
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [Abstract] [Full Text] [Related]

  • 8. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH, Walsh TJ.
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [Abstract] [Full Text] [Related]

  • 9. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacology and clinical use of caspofungin.
    Hope WW, Shoham S, Walsh TJ.
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
    [Abstract] [Full Text] [Related]

  • 16. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
    van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.
    J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
    [Abstract] [Full Text] [Related]

  • 17. Caspofungin acetate: an antifungal agent.
    Hoang A.
    Am J Health Syst Pharm; 2001 Jul 01; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
    [Abstract] [Full Text] [Related]

  • 18. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA, Scott LJ.
    Drugs; 2008 Jul 01; 68(15):2225-55. PubMed ID: 18840009
    [Abstract] [Full Text] [Related]

  • 19. Caspofungin: the first representative of a new antifungal class.
    Letscher-Bru V, Herbrecht R.
    J Antimicrob Chemother; 2003 Mar 01; 51(3):513-21. PubMed ID: 12615851
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
    Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N.
    Cancer; 2006 Jan 15; 106(2):466-73. PubMed ID: 16353208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.